Sato Aki, Sakai Naoko, Shinbo Junsuke, Hashidate Hideki, Igarashi Shuichi, Kakita Akiyoshi, Yamazaki Motoyoshi
Department of Neurology, Niigata City General Hospital.
Rinsho Shinkeigaku. 2014;54(1):32-7. doi: 10.5692/clinicalneurol.54.32.
The patient was a 55-year-old male who had prominent fasciculation and muscle cramps. Muscle weakness and atrophy of the trunk, respiratory system, and extremities gradually progressed. On the basis of these features, we diagnosed this patient as having amyotrophic lateral sclerosis (ALS), however, the upper motor neuron signs were not significant. Following the detection of the anti-voltage gated potassium channel (VGKC) complex antibody at 907.5 pM (normal < 100 pM) and repetitive discharge in a nerve conduction study, immunotherapy with intravenous immunoglobulin, methylprednisolone (mPSL), double filtration plasmapheresis (DFPP), ciclosporin, and rituximab was introduced. mPSL and DFPP showed only tentative effectiveness for fasciculation and muscle cramps, respectively. Thereafter, muscle weakness progressed. The patient died of type II respiratory failure at the age of 57 years, about 2 years after the onset of the disease. At autopsy, a histopathological diagnosis of ALS with lower-motor-predominant degeneration was made. Characteristic cellular features, including Bunina bodies in the remaining lower motor neurons and phosphorylated TAR DNA-binding protein 43-kDa (pTDP-43)-immunopositive inclusions in both upper and lower motor neuron systems, were evident. At present, an immunological role of the anti-VGKC complex antibody in the development of cramp-fasciculation syndrome has been speculated. In this ALS patient, the antibodies might be associated with pathomechanisms underlying the characteristic symptoms.
该患者为一名55岁男性,有明显的肌束震颤和肌肉痉挛。躯干、呼吸系统及四肢的肌无力和萎缩逐渐进展。基于这些特征,我们将该患者诊断为肌萎缩侧索硬化症(ALS),然而,上运动神经元体征并不显著。在检测到抗电压门控钾通道(VGKC)复合物抗体浓度为907.5 pM(正常<100 pM)且神经传导研究显示有重复放电后,开始采用静脉注射免疫球蛋白、甲泼尼龙(mPSL)、双重滤过血浆置换(DFPP)、环孢素和利妥昔单抗进行免疫治疗。mPSL和DFPP分别仅对肌束震颤和肌肉痉挛显示出暂时疗效。此后,肌无力进展。患者在疾病发作约2年后,于57岁时死于II型呼吸衰竭。尸检时,做出了以低运动神经元为主的变性的ALS组织病理学诊断。特征性细胞特征明显,包括剩余低运动神经元中的布尼亚小体以及上下运动神经元系统中磷酸化TAR DNA结合蛋白43 kDa(pTDP - 43)免疫阳性包涵体。目前,已推测抗VGKC复合物抗体在痉挛 - 肌束震颤综合征发展中的免疫作用。在这名ALS患者中,这些抗体可能与特征性症状的发病机制有关。